Tokyo, May 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061620) titled 'A study evaluating changes in insulin resistance during the early phase of teprotumumab administration for thyroid eye disease' on May 18.
Study Type:
Observational
Primary Sponsor:
Institute - Kagawa univercity
Condition:
Condition - Thyroid eye disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To verify the hypothesis that insulin resistance (HOMA-IR) increases from baseline to after the third dose in patients receiving teprotumumab for thyroid eye disease.
Basic objectives2 - Safety
Eligibility:
Age-lower limit - 18
years-old
= 3 out of 7 points, or infla...